摘要
为探讨治疗非新生血管性顽固性青光眼的有效方法,对37例(46眼)非新生血管性顽固性青光眼,随机分为HAD房水引流物置入术组(HAD组,24眼)与小梁切除术联合应用丝裂霉素C治疗组(MMC组,22只眼),平均随访158月(3~34月)。术后一年眼压峰值(X±SD):HAD组为170±64mmHg,MMC组为187±75mmHg(P<005);眼压下降率(X±SD):HAD组为635%±179%,MMC组为496%±174%(P<005)。手术成功率:术后一年HAD组为900%,MMC组为824%(P>005);术后一年半时,HAD组为889%,MMC组为700%(P>005);术后两年时,HAD组为833%,MMC组为571%(P>005)。术后并发症,MMC组前房积血(364%)多见(P<001),此外还可见到低眼压性黄斑病变(45%)等并发症;HAD组亦有引流管前房端纤维膜闭(167%),引流管与其周围虹膜粘连(83%)等并发症。结果:本组病例行HAD房水引流物置入术的手术成功率与国外同类产品相似。在常规滤过性手术联合应用抗瘢痕形成药物治疗顽固性青光眼失败?
To research the effective management in non neovascular glaucoma.37 patients(46 eyes)with non neovascular refractory glaucoma subgrouped randomly into Hunan Aqueous Drainage implantation operation group(HAD group,24 eyes)and Trabeculectomy combined with Mitomycin C group as control group(MMC group,22eyes). Results:The average followed up was 15 8(range,3~34)months.The IOP peak(±S)at one year after surgery was 17 0±6 4mmHg in HAD group and 18 7±7 5mmHg in MMC group(P<0 05).The percentage of IOP decreased(±S)was 63 5%±17 9% in HAD group and 49 6%±17 4% in MMC group(P<0 05).The success rates(IOP≤21mmHg)at one year,one and half years and two years intervals were 90 0%,88 9%,83 3% in HAD group and 82 4%,70 0%,57 1% in MMC group,respectively.The commonly postoperative complications were hyphema(36 4%)(p<0 01)and other ones,such as hypotous maculopathy(4 5%)were found in MMC group.There were blockage of the proximal end of the tube in the anterior chamber of the eye by fibrous membrane(16 7%)and anterior synechia around the proximal orifice of the tube(8 3%)and other complications in HAD group.Conclusion:The success rate of HAD implantation surgery was consistent with the foreign same type products.After refractory glaucoma treated by routinely filtering surgery combined with antifibroblasts proliferation drugs was failed,this implantation surgery can be chosen.Therefore,a safe and effective management in refractory glaucoma was recommended,but a follow up study should be conducted to confirm the long term results.
出处
《中国实用眼科杂志》
CSCD
1998年第4期226-229,共4页
Chinese Journal of Practical Ophthalmology